Adrenal Angiosarcoma: A Diagnostic Dilemma

Primary angiosarcoma of the adrenal gland is both a rare and aggressive malignancy. Differentiating it from more common adrenal masses such as adrenal adenomas, adrenal cortical carcinomas, and metastatic carcinomas is one of several diagnostic challenges. Immunohistochemical analysis is imperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Antao, Nirav, Ogawa, Michael, Ahmed, Zarir, Piao, Jinhua, Poddar, Nishant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784971/
https://www.ncbi.nlm.nih.gov/pubmed/31612098
http://dx.doi.org/10.7759/cureus.5370
_version_ 1783457824031899648
author Antao, Nirav
Ogawa, Michael
Ahmed, Zarir
Piao, Jinhua
Poddar, Nishant
author_facet Antao, Nirav
Ogawa, Michael
Ahmed, Zarir
Piao, Jinhua
Poddar, Nishant
author_sort Antao, Nirav
collection PubMed
description Primary angiosarcoma of the adrenal gland is both a rare and aggressive malignancy. Differentiating it from more common adrenal masses such as adrenal adenomas, adrenal cortical carcinomas, and metastatic carcinomas is one of several diagnostic challenges. Immunohistochemical analysis is imperative to arrive at the correct diagnosis. Treatment typically involves surgery and adjuvant chemotherapy, but prognosis remains poor.
format Online
Article
Text
id pubmed-6784971
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-67849712019-10-14 Adrenal Angiosarcoma: A Diagnostic Dilemma Antao, Nirav Ogawa, Michael Ahmed, Zarir Piao, Jinhua Poddar, Nishant Cureus Oncology Primary angiosarcoma of the adrenal gland is both a rare and aggressive malignancy. Differentiating it from more common adrenal masses such as adrenal adenomas, adrenal cortical carcinomas, and metastatic carcinomas is one of several diagnostic challenges. Immunohistochemical analysis is imperative to arrive at the correct diagnosis. Treatment typically involves surgery and adjuvant chemotherapy, but prognosis remains poor. Cureus 2019-08-12 /pmc/articles/PMC6784971/ /pubmed/31612098 http://dx.doi.org/10.7759/cureus.5370 Text en Copyright © 2019, Antao et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Antao, Nirav
Ogawa, Michael
Ahmed, Zarir
Piao, Jinhua
Poddar, Nishant
Adrenal Angiosarcoma: A Diagnostic Dilemma
title Adrenal Angiosarcoma: A Diagnostic Dilemma
title_full Adrenal Angiosarcoma: A Diagnostic Dilemma
title_fullStr Adrenal Angiosarcoma: A Diagnostic Dilemma
title_full_unstemmed Adrenal Angiosarcoma: A Diagnostic Dilemma
title_short Adrenal Angiosarcoma: A Diagnostic Dilemma
title_sort adrenal angiosarcoma: a diagnostic dilemma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784971/
https://www.ncbi.nlm.nih.gov/pubmed/31612098
http://dx.doi.org/10.7759/cureus.5370
work_keys_str_mv AT antaonirav adrenalangiosarcomaadiagnosticdilemma
AT ogawamichael adrenalangiosarcomaadiagnosticdilemma
AT ahmedzarir adrenalangiosarcomaadiagnosticdilemma
AT piaojinhua adrenalangiosarcomaadiagnosticdilemma
AT poddarnishant adrenalangiosarcomaadiagnosticdilemma

Ejemplares similares